Comparison effect of three different drug combinations on Blood Pressure and Heart rate of patients under Bronchoscopy

Comparing the effects of Propofol-Ketamine with Propofol-Remifentanile on blood pressure and heart rate changes in patients candidate for Fibro optic Bronchoscopy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130311012782N33

Enrollment

Registered

2019-08-17

Start date

2019-09-22

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchoscopy.

Interventions

Intervention 1: Intervention group: receive 1ug/kg injectable Remifentanil (Razavi Pharmacational institute) with 0.5 mg/kg ketamin(made by Bremore Company) through intravenous infusion. Intervention

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ASA (American Society of Anesthesiologists) < 4 patients candidate for bronchoscopy

Exclusion criteria

Exclusion criteria: body mass index>35 history of alcohol consumption or addiction history of severe allergy history of psychologic diseases history of epilepsy of seizure patient with unstable status

Design outcomes

Primary

Measure	Time frame
Blood Pressure. Timepoint: every 5 minutes during procedure and recovery. Method of measurement: palsoxymetery.	—

Secondary

Measure	Time frame
Heart rate. Timepoint: every 5 minutes during procedure and recovery. Method of measurement: palsoxymetery.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Mehrabi

Esfahan University of Medical Sciences

al.mehrabi@gmail.com+98 31 3792 8081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026